The cost-effectiveness of spinal cord stimulation in the treatment of failed back surgery syndrome

Clinical Journal of Pain

Volumn 26, Issue 6, 2010, Pages 463-469

  Taylor, Rod S ^a   Ryan, James ^b   O'Donnell, Ruairi ^b   Eldabe, Sam ^c   Kumar, Krishna ^d   North, Richard B ^e,f  

^a PENINSULA MEDICAL SCHOOL   (United Kingdom)

^b Decision Resources Group   (United Kingdom)

^c JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

^d REGINA GENERAL HOSPITAL   (Canada)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f Neuromodulation Foundation   (United States)

Author keywords

cost effectiveness; failed back surgery syndrome; modeling study; neuropathic pain; spinal cord stimulation

Indexed keywords

ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FAILED BACK SURGERY SYNDROME; HUMAN; INTERMETHOD COMPARISON; PRIORITY JOURNAL; PULSE GENERATOR; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; REOPERATION; SENSITIVITY ANALYSIS; SPINAL CORD STIMULATION; BACK INJURIES; COST BENEFIT ANALYSIS; ELECTROSTIMULATION THERAPY; HEALTH CARE COST; NEUROSURGERY; PAIN MEASUREMENT; PROBABILITY; PROCEDURES; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; STATISTICAL MODEL; TREATMENT FAILURE; UNITED KINGDOM;

BACK INJURIES; COST-BENEFIT ANALYSIS; ELECTRIC STIMULATION THERAPY; GREAT BRITAIN; HEALTH EXPENDITURES; HUMANS; MODELS, STATISTICAL; NEUROSURGICAL PROCEDURES; PAIN MEASUREMENT; PROBABILITY; QUALITY OF LIFE; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TREATMENT FAILURE;

EID: 77953904931     PISSN: 07498047     EISSN: 15365409     Source Type: Journal    
DOI: 10.1097/AJP.0b013e3181daccec     Document Type: Article

References (28)

1. North RB, Kidd DH, Zahurak M, et al. Spinal cord stimulation for chronic, intractable pain: experience over two decades. Neurosurgery. 1993;32:384-394.
2. Wilkinson HA. The Failed back Syndrome: Etiology and Therapy. Philadelphia: Harper & Row; 1991.
3. Berger A, Dukes EM, Oster G. Clinical characteristics and economic costs of patients with painful neuropathic disorders. J Pain. 2004;5:143-149.
4. McDermott AM, Toelle TR, Rowbotham DJ, et al. The burden of neuropathic pain: results from a cross-sectional survey. Eur J Pain. 2006;10:127-135.
5. Manca A, Kumar K, Taylor RS, et al. Quality of life, resource consumption and costs of spinal cord stimulation versus conventional medical management in neuropathic pain patients with failed back surgery syndrome (PROCESS trial). Eur J Pain. 2008;12:1047-1058.
6. Hazard RG. Failed back surgery syndrome: surgical and non-surgical approaches. Clin Orthop Relat Res. 2006;443:228-232.
7. Kumar K, Taylor RS, Jacques L, et al. Spinal cord stimulation versus conventional medical management for neuropathic pain: a multicentre randomised controlled trial in patients with failed back surgery syndrome. Pain. 2007;132:179-188.
8. Ragab A, Deshazo RD. Management of back pain in patients with previous back surgery. Am J Med. 2008;121:272-278.
9. North RB, Kidd DH, Farrokhi F, et al. Spinal cord stimulation versus repeated lumbosacral spine surgery for chronic pain: a randomized, controlled trial. Neurosurgery. 2005;56: 98-106.
10. Cruccu G, Aziz TZ, Garcia-Larrea L, et al. EFNS Recommendations on neurostimulation therapy for neuropathic pain. Eur J Neurol. 2007;14:952-970.
11. North R, Shipley J, Prager J, et al. Practice parameters for the use of spinal cord stimulation in the treatment of chronic neuropathic pain. Pain Med. 2007;8(suppl 4):S200-S275.
12. Detsky AS, Laupacis A. Relevance of cost-effectiveness analysis to clinicians and policy makers. JAMA. 2007;298:221-224.
13. Taylor RJ, Taylor RS. Spinal cord stimulation for failed back surgery syndrome: a decision-analytic model and cost-effectiveness analysis. Int J Technol Assess Health Care. 2005; 21:351-358.
14. North RB, Kidd D, Shipley J, et al. Spinal cord stimulation versus reoperation for failed back surgery syndrome: a cost effectiveness and cost utility analysis based on a randomized, controlled trial. Neurosurgery. 2007;61:361-368.
15. Kumar K, Taylor RS, Jacques L, et al. The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multi-center trial of the effectiveness of spinal cord stimulation. Neurosurgery. 2008;63:762-768.
16. National Institute for Health and Clinical Excellence. Spinal Cord Stimulation for Chronic Pain of Neuropathic or Ischaemic Origin. London: National Institute for Health and Clinical Excellence; 2008.
17. National Institute for Health and Clinical Excellence. Guide to the Methods of Technology Appraisal. London: National Institute for Health and Clinical Excellence; 2004.
18. Kumar K, Hunter G, Demeria D. Spinal cord stimulation in treatment of chronic benign pain: challenges in treatment planning and present status, a 22-year experience. Neurosur-gery. 2006;58:481-496.
19. UK Office of National Statistics. http://www.statistics.gov.uk [Accessed on: September 30, 2009].
20. Taylor RS, Van Buyten JP, Buchser E. Spinal cord stimulation for chronic back and leg pain and failed back surgery syndrome: a systematic review and analysis of prognostic factors. Spine. 2005;30:152-160.
21. National Health Service England, Hospital Episodes Statistics. Totals report for Procedure A483 (Insertion of neurostimu-lator adjacent to spinal cord) for the all SHA's (Strategic Health Authorities) of treatment 2005/2006. Available at: http://www.hesonline.nhs.uk/Ease/servlet/ContentServer?siteID= 1937&categoryID=537 [Accessed on: September 30 2009].
22. Rivero-Arias O, Campbell H, Gray A, et al. Surgical stabilisation of the spine compared with a programme of intensive rehabilitation for the management of patients with chronic low back pain: cost utility analysis based on a randomised controlled trial. BMJ. 2005;330:1239-1245.
23. Kumar K, Malik S, Demeria D. Treatment of chronic pain with spinal cord stimulation versus alternative therapies: cost-effectiveness analysis. Neurosurgery. 2002;51:106-116.
24. National Health Service reference costs 2003 and National tariff 2004 (Payment by results core tools 2004). http://www.dh.gov.uk/en/ Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH-4070195 [Accessed on: September 30, 2009].
25. Fenwick E, Claxton K, Sculpher M. Representing uncertainty: the role of cost-effectiveness acceptability curves. Health Econ. 2001;10:779-787.
26. Rawlins MD, Culyer AJ. National Institute for Clinical Excellence and its value judgments. BMJ. 2004;329:224-227.
27. Hornberger J, Kumar K, Verhulst E, et al. Rechargeable spinal cord stimulation versus non-rechargeable systems for patients with failed back surgery syndrome: a cost-consequences analysis. Clin J Pain. 2008;24:244-252.
28. Taylor RS. Epidemiology of refractory neuropathic pain. Pain Pract. 2006;6:22-26.